Since 1998, Intellipharmaceutics has been an innovator in the international pharmaceutical market. The Company s patented Hypermatrix technology is a unique and validated multidimensional controlled-release drug delivery platform that can be applied to the development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics is developing a pipeline of both generic and new drugs across a range of therapeutic classes.